RESUMEN
The generation of human induced pluripotent stem cells (hiPSCs) derived from an autologous extraembryonic fetal source is an innovative personalized regenerative technology that can transform own-self cells into embryonic stem-like ones. These cells are regarded as a promising candidate for cell-based therapy, as well as an ideal target for disease modeling and drug discovery. Thus, hiPSCs enable researchers to undertake studies for treating diseases or for future applications of in utero therapy. We used a polycistronic lentiviral vector (hSTEMCCA-loxP) encoding OCT4, SOX2, KLF4, and cMYC genes and containing loxP sites, excisible by Cre recombinase, to reprogram patient-specific fetal cells derived from prenatal diagnosis for several genetic disorders, such as myotonic dystrophy type 1 (DM1), ß-thalassemia (ß-Thal), lymphedema-distichiasis syndrome (LDS), spinal muscular atrophy (SMA), cystic fibrosis (CF), as well as from wild-type (WT) fetal cells. Because cell types tested to create hiPSCs influence both the reprogramming process efficiency and the kinetics, we used chorionic villus (CV) and amniotic fluid (AF) cells, demonstrating how they represent an ideal cell resource for a more efficient generation of hiPSCs. The successful reprogramming of both CV and AF cells into hiPSCs was confirmed by specific morphological, molecular, and immunocytochemical markers and also by their teratogenic potential when inoculated in vivo. We further demonstrated the stability of reprogrammed cells over 10 and more passages and their capability to differentiate into the three embryonic germ layers, as well as into neural cells. These data suggest that hiPSCs-CV/AF can be considered a valid cellular model to accomplish pathogenesis studies and therapeutic applications.
Asunto(s)
Feto/citología , Células Madre Pluripotentes Inducidas/metabolismo , Animales , Células Cultivadas , Reprogramación Celular , Muestra de la Vellosidad Coriónica , Fibrosis Quística/embriología , Pestañas/anomalías , Pestañas/embriología , Femenino , Feto/fisiología , Vectores Genéticos , Humanos , Factor 4 Similar a Kruppel , Factores de Transcripción de Tipo Kruppel/genética , Lentivirus/genética , Linfedema/embriología , Ratones , Atrofia Muscular Espinal/embriología , Distrofia Miotónica/embriología , Factor 3 de Transcripción de Unión a Octámeros/genética , Embarazo , Proteínas Proto-Oncogénicas c-myc/genética , Factores de Transcripción SOXB1/genética , Transgenes , Talasemia beta/embriologíaRESUMEN
PURPOSE: We present in this study our 10years experience in prenatal diagnosis of cystic fibrosis performed in the Tunisian population. PATIENTS AND METHODS: Based on family history, 40 Tunisian couples were selected for prenatal diagnosis. Fetal DNA was isolated from amniotic fluid collected by transabdominal amniocentesis or from chronic villi by transcervical chorionic villus sampling. The genetic analysis for cystic fibrosis mutations was performed by denaturant gradient gel electrophoresis and denaturing high-pressure liquid phase chromatography. We performed microsatellites analysis by capillary electrophoresis in order to verify the absence of maternal cell contamination. RESULTS: Thirteen fetuses were affected, 21 were heterozygous carriers and 15 were healthy with two normal alleles of CFTR gene. Ten couples opted for therapeutic abortion. The microsatellites genotyping showed the absence of contamination of the fetal DNA by maternal DNA in 93.75%. CONCLUSION: Our diagnostic strategy provides rapid and reliable prenatal diagnosis at risk families of cystic fibrosis.
Asunto(s)
Amniocentesis , Muestra de la Vellosidad Coriónica , Regulador de Conductancia de Transmembrana de Fibrosis Quística/genética , Fibrosis Quística/diagnóstico , Aborto Eugénico , Alelos , Árabes/genética , Muestra de la Vellosidad Coriónica/efectos adversos , Cromatografía Líquida de Alta Presión , Fibrosis Quística/embriología , Fibrosis Quística/epidemiología , Fibrosis Quística/genética , Regulador de Conductancia de Transmembrana de Fibrosis Quística/análisis , Enfermedades en Gemelos/diagnóstico , Enfermedades en Gemelos/genética , Electroforesis en Gel de Poliacrilamida , Femenino , Muerte Fetal/etiología , Asesoramiento Genético , Genotipo , Humanos , Masculino , Repeticiones de Microsatélite , Embarazo , Embarazo Gemelar , Estudios Retrospectivos , Túnez/epidemiologíaRESUMEN
Cystic fibrosis is an autosomal recessive disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator gene. This disorder produces a variable phenotype including lung disease, pancreatic insufficiency, and meconium ileus plus bilateral agenesis of the vas deferens causing obstructive azoospermia and male infertility. Preimplantation genetic diagnosis is an alternative that allows identification of embryos affected by this or other genetic diseases. We report a case of couple with cystic fibrosis; the woman had the I148 T mutation and the man had the Delta F508 gene mutation. The couple underwent in vitro fertilization, associated with preimplantation genetic diagnosis, and with subsequent selection of healthy embryos for uterine transfer. The result was an uneventful pregnancy and delivery of a healthy male baby.
Asunto(s)
Fibrosis Quística/diagnóstico , Fertilización In Vitro/métodos , Mutación , Diagnóstico Preimplantación/métodos , Adulto , Biopsia , Blastocisto/patología , Fibrosis Quística/embriología , Fibrosis Quística/genética , Femenino , Humanos , Masculino , Ilustración Médica , Embarazo , Resultado del Embarazo , Resultado del TratamientoRESUMEN
Cystic fibrosis is an autosomal recessive disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator gene. This disorder produces a variable phenotype including lung disease, pancreatic insufficiency, and meconium ileus plus bilateral agenesis of the vas deferens causing obstructive azoospermia and male infertility. Preimplantation genetic diagnosis is an alternative that allows identification of embryos affected by this or other genetic diseases. We report a case of couple with cystic fibrosis; the woman had the I148 T mutation and the man had the Delta F508 gene mutation. The couple underwent in vitro fertilization, associated with preimplantation genetic diagnosis, and with subsequent selection of healthy embryos for uterine transfer. The result was an uneventful pregnancy and delivery of a healthy male baby.
A fibrose cística é uma doença autossômica recessiva causada por mutações no gene regulador de condutância transmembrana na fibrose cística. Produz fenótipo variável, incluindo doença pulmonar, insuficiência pancreática, íleo meconial, além de agenesia bilateral dos ductos deferentes, causando azoospermia obstrutiva e infertilidade masculina. O diagnóstico genético pré-implantacional é uma alternativa diagnóstica, que permite identificar embriões portadores de fibrose cística e outras doenças genéticas. Relatamos o caso de um casal portador de fibrose cística, sendo a mulher portadora da mutação I148 T e o homem da mutação gênica Delta F508. O casal foi submetido a técnicas de fertilização in vitro associadas ao diagnóstico genético pré-implantacional, com consequente seleção de embriões saudáveis, que foram transferidos para o útero, resultando em gravidez sem intercorrências e com feto saudável, do sexo masculino.
Asunto(s)
Adulto , Femenino , Humanos , Masculino , Embarazo , Fibrosis Quística/diagnóstico , Fertilización In Vitro/métodos , Mutación , Diagnóstico Preimplantación/métodos , Biopsia , Blastocisto/patología , Fibrosis Quística/embriología , Fibrosis Quística/genética , Ilustración Médica , Resultado del Embarazo , Resultado del TratamientoRESUMEN
INTRODUCTION: Cystic fibrosis or mucoviscidosis is a genetically caused disease. The intensity of disease and histopathological changes grow throughout the life. According to the literature, pathological changes characteristic of cystic fibrosis become noticeable around the sixth month of life. CASE REPORT: After amniocentesis of a 5-lunar month-old fetus had been done, which confirmed cystic fibrosis, the Ethics Commission approved the preterm labor. The autopsy and histopathological analysis demonstrated the existence of typical histopathological changes in the pancreas and intestines. DISCUSSION: In the late fetal period or during the period around the delivery, cystic fibrosis is usually manifested as meconial cap with or without obstruction of the intestinal lumen. Morphological changes in the exocrine glands usually develop only after birth. In this case, the existence of meconial obstruction, as well as the typical acidofil content in the secretory ducts and acini of the pancreas was confirmed, which is unusual for the fetal age of five months.
Asunto(s)
Fibrosis Quística/embriología , Enfermedades Fetales/patología , Fibrosis Quística/diagnóstico , Fibrosis Quística/patología , Femenino , Edad Gestacional , Humanos , EmbarazoRESUMEN
Sterility due to bilateral destruction in utero or in early infancy resulting in congenital absence of the vas deferens is the rule in male patients with cystic fibrosis. To understand the developmental pattern of this anomaly, the microscopic morphology of the male excretory system was analyzed during development and the expression of the cystic fibrosis transmembrane conductance regulator protein was explored by immunohistochemistry. We observed that cystic fibrosis fetuses had no excretory ducts agenesis or obstruction until 22 weeks of gestation. However, a focal inflammatory pattern and mucinous plugs in the oldest cystic fibrosis case suggested a disruptive mechanism. Immunolabeling of cytoplasmic epithelial cystic fibrosis transmembrane conductance regulator protein was demonstrated in all cystic fibrosis and control cases with a similar pattern of expression of the protein between age-matched controls and cystic fibrosis cases. At midgestation, an apical intensification appeared in both cystic fibrosis and control cases and was stable during the remainder of fetal life. No gradient of intensity could be detected between the different segments of the excretory tract. These findings are different from those reported in adults. The absence of any morphologic anomaly until 22 weeks of gestation, the focal destruction of the epithelial structures during the second trimester, and the chronological pattern of expression of cystic fibrosis transmembrane conductance regulator are of interest for a better understanding of the pathophysiology of this disease.
Asunto(s)
Regulador de Conductancia de Transmembrana de Fibrosis Quística/metabolismo , Fibrosis Quística/embriología , Conducto Deferente/embriología , Biomarcadores/metabolismo , Fibrosis Quística/metabolismo , Fibrosis Quística/patología , Citoplasma/metabolismo , Epidídimo/embriología , Epidídimo/metabolismo , Células Epiteliales/metabolismo , Células Epiteliales/patología , Desarrollo Fetal , Edad Gestacional , Humanos , Masculino , Red Testicular/embriología , Red Testicular/metabolismo , Factores de Tiempo , Conducto Deferente/metabolismo , Conducto Deferente/patologíaRESUMEN
OBJECTIVES: Fetal gallbladder non-visualization on prenatal ultrasound in the second trimester is uncommon and in most cases the gallbladder is detected eventually. Associations of gallbladder non-visualization with cystic fibrosis, aneuploidy, agenesis of the gallbladder and biliary atresia have been reported. We present our experience and review the literature. METHODS: During the study period from January 2004 to June 2009 we collected prospectively cases of non-visualization of the fetal gallbladder in the second trimester. In each case the fetus was evaluated by two examiners on at least two occasions, at least a week apart. Cases with no additional sonographic malformations were designated as isolated. Further evaluation included follow-up scans and a meticulous search for fetal anomalies. All patients were offered genetic consultation. Cystic fibrosis testing, amniocentesis for karyotyping and analysis of fetal digestive enzymes in the amniotic fluid were offered. RESULTS: We collected 21 cases of non-visualization of the fetal gallbladder, 16 of which were isolated and five of which had additional malformations. In four of these five, the associated anomalies were severe and the pregnancies were terminated for aneuploidy (two cases of trisomy 18 and one triploidy) or for the severity of the associated anomalies. Associated anomalies included left isomerism with complex cardiac anomaly and intrauterine growth restriction with multisystem anomalies. The fifth fetus had interrupted inferior vena cava with azygos continuation without other anomalies and the child was alive and well at the age of 4 years. In 15 of the 16 isolated cases, antenatal and postnatal development were normal at the last follow-up, ranging from 4 months to 2.5 years. One case of cystic fibrosis was diagnosed prenatally and this pregnancy was terminated. There were no diagnoses of abnormal karyotype or biliary atresia among cases of isolated non-visualization of the gallbladder. CONCLUSIONS: When prenatal non-visualization of the fetal gallbladder is associated with other severe malformation, aneuploidy should be suspected. When it is isolated, if cystic fibrosis is ruled out, the outcome is good.
Asunto(s)
Fibrosis Quística/diagnóstico por imagen , Vesícula Biliar/diagnóstico por imagen , gamma-Glutamiltransferasa/sangre , Amniocentesis , Fibrosis Quística/sangre , Fibrosis Quística/embriología , Femenino , Vesícula Biliar/anomalías , Vesícula Biliar/embriología , Edad Gestacional , Humanos , Recién Nacido , Cariotipificación , Masculino , Embarazo , Resultado del Embarazo , Segundo Trimestre del Embarazo , Estudios Prospectivos , Ultrasonografía PrenatalRESUMEN
INTRODUCTION: The high genetic heterogeneity in populations with a wide spectrum of mutations in the CF transmembrane conductance regulator gene (CFTR), makes the detection of mutations a very hard and difficult task, thereby limiting the accurate diagnosis of the disease, mainly in patients with uncharacterized mutations. MATERIAL AND METHODS: Molecular strategies, like targeted identification of the most frequent CFTR mutations in Mexican population combined with linkage analysis using markers, is very useful for carrier detection and for prenatal diagnosis in affected families with CF. In this paper we show that the combination of methodologies was a crucial alternative to reach a precise prenatal CF diagnosis. We documented CF diagnosis in a 14th-week fetus combining the screening of the most common mutations in Mexican population with linkage analysis of two extragenic polymorphisms (XV2C/TaqI and KM19/PstI). RESULTS: We determined that the fetus inherited the PG542X mutation from its mother and an unknown mutation from its father through the chromosomal phases analysis.
Asunto(s)
Regulador de Conductancia de Transmembrana de Fibrosis Quística/genética , Fibrosis Quística/diagnóstico , Diagnóstico Prenatal , Niño , Fibrosis Quística/embriología , Fibrosis Quística/genética , Análisis Mutacional de ADN , Femenino , Ligamiento Genético , Haplotipos , Heterocigoto , Humanos , Masculino , México/epidemiología , Linaje , Polimorfismo de Longitud del Fragmento de Restricción , EmbarazoRESUMEN
Grade III fetal bowel hyperechogenicity and/or loop dilatation observed at the second trimester of pregnancy can be due to several disease conditions, including cystic fibrosis (CF). Screening for frequent CF mutations is performed as a first step and, in certain situations, such as when a frequent CF mutation is found in the fetus, the increased risk of CF justifies an in-depth study of the second allele. To determine the contribution of large CFTR gene rearrangements in such cases, detected using a semiquantitative fluorescent multiplex PCR (QFM-PCR) assay, we collated data on 669 referrals related to suspicion of CF in fetuses from 1998 to 2009. Deletions were found in 5/70 cases in which QFM-PCR was applied, dele19, dele22_23, dele2_6b, dele14b_15 and dele6a_6b, of which the last three remain undescribed. In 3/5 cases, hyperechogenicity was associated with dilatation and/or gallbladder anomalies. Of the total cases of CF recognized in the subgroup of first-hand referrals, deletions represent 16.7% of CF alleles. Our study thus strengthens the need to consider large CFTR gene rearrangements in the diagnosis strategy of fetal bowel anomalies, in particular in the presence of multiple anomalies.
Asunto(s)
Regulador de Conductancia de Transmembrana de Fibrosis Quística/genética , Fibrosis Quística/diagnóstico , Fibrosis Quística/genética , Intestino Ecogénico/genética , Reordenamiento Génico , Pruebas Genéticas , Diagnóstico Prenatal , Anomalías Múltiples/embriología , Anomalías Múltiples/genética , Aberraciones Cromosómicas , Fibrosis Quística/embriología , Análisis Mutacional de ADN , Femenino , Enfermedades Fetales/diagnóstico , Enfermedades Fetales/genética , Vesícula Biliar/anomalías , Humanos , Recién Nacido , Intestinos/embriología , Mutación Puntual , Reacción en Cadena de la Polimerasa , Embarazo , Segundo Trimestre del Embarazo , Eliminación de SecuenciaRESUMEN
OBJECTIVE: When the fetal gallbladder is not seen at ultrasound (US) scan, to propose a diagnostic method of differentiating fetuses who are healthy or have minor anomalies from fetuses with severe anomalies requiring intensive management. METHOD: We present four clinical cases illustrating this variability, together with additional examinations: karyotyping, screening for cystic fibrosis mutations, amniotic fluid digestive enzyme activities. RESULTS: The four examples we present-biliary duct atresia, biliary agenesis, gallbladder reveal at birth, and cystic fibrosis-illustrate the difficulties of making both diagnosis and prognosis prenatally when the gallbladder is not visualized. Laboratory assays allowed prenatal management. CONCLUSION: Failure to visualize the gallbladder prenatally may indicate fetal diseases of highly variable prognosis, but may also sometimes be followed by postnatal visualization in a child free of any disease. Prenatal management could help in defining diagnosis and prognosis.
Asunto(s)
Vesícula Biliar/diagnóstico por imagen , Edad Gestacional , Ultrasonografía Prenatal , Adulto , Fosfatasa Alcalina/análisis , Líquido Amniótico/enzimología , Conductos Biliares/anomalías , Fibrosis Quística/diagnóstico , Fibrosis Quística/diagnóstico por imagen , Fibrosis Quística/embriología , Femenino , Vesícula Biliar/anomalías , Vesícula Biliar/embriología , Humanos , Leucil Aminopeptidasa/análisis , Masculino , Embarazo , Resultado del Embarazo , Segundo Trimestre del Embarazo , gamma-Glutamiltransferasa/análisisRESUMEN
BACKGROUND: Human embryonic stem cells (hESCs) suitable for future transplantation therapy should preferably be developed in an animal-free system. Our objective was to develop a laser-based system for the isolation of the inner cell mass (ICM) that can develop into hESC lines, thereby circumventing immunosurgery that utilizes animal products. METHODS: Hatching was assisted by micromanipulation techniques through a laser-drilled orifice in the zona pellucida of 13 abnormal preimplantation genetic diagnosed blastocysts. ICMs were dissected from the trophectoderm by a laser beam and plated on feeders to derive hESC lines. RESULTS: eight ICMs were isolated from nine hatched blastocysts and gave rise to three hESC lines affected by myotonic dystrophy type 1, hemophilia A and a carrier of cystic fibrosis 405 + 1G > A mutation. Five blastocysts that collapsed during assisted hatching or ICM dissection were plated whole, giving rise to an additional line affected by fragile X. All cell lines expressed markers of pluripotent stem cells and differentiated in vitro and in vivo into the three germ layers. CONCLUSIONS: These hESC lines can serve as an important model of the genetic disorders that they carry. Laser-assisted isolation of the ICMs may be applied for the derivation of new hESC lines in a xeno-free system for future clinical applications.
Asunto(s)
Línea Celular , Disección/métodos , Embrión de Mamíferos/patología , Células Madre Embrionarias/patología , Fertilización In Vitro , Rayos Láser , Diagnóstico Preimplantación , Biomarcadores/metabolismo , Masa Celular Interna del Blastocisto/patología , Diferenciación Celular , Separación Celular , Fibrosis Quística/diagnóstico , Fibrosis Quística/embriología , Fibrosis Quística/genética , Fibrosis Quística/patología , Células Madre Embrionarias/metabolismo , Síndrome del Cromosoma X Frágil/diagnóstico , Síndrome del Cromosoma X Frágil/embriología , Síndrome del Cromosoma X Frágil/patología , Hemofilia A/diagnóstico , Hemofilia A/embriología , Hemofilia A/patología , Heterocigoto , Humanos , Distrofia Miotónica/diagnóstico , Distrofia Miotónica/embriología , Distrofia Miotónica/patología , Células Madre Pluripotentes/metabolismoRESUMEN
In cystic fibrosis patients, inflammation is often considered to be secondary to chronic infections. In the present study, we show increased levels of pro-inflammatory proteins in the lungs of a cystic fibrosis foetus compared to the lungs of two normal foetuses. Our findings suggest therefore the existence of an early intrinsic pro-inflammatory state in cystic fibrosis airways.
Asunto(s)
Bronquitis/embriología , Fibrosis Quística/embriología , Citocinas/metabolismo , Enfermedades Fetales/metabolismo , FN-kappa B/metabolismo , Biomarcadores/metabolismo , Bronquitis/metabolismo , Bronquitis/patología , Fibrosis Quística/metabolismo , Fibrosis Quística/patología , Femenino , Enfermedades Fetales/patología , Técnica del Anticuerpo Fluorescente , Edad Gestacional , Humanos , Inmunohistoquímica , Pulmón/metabolismo , Pulmón/patología , Microscopía Confocal , Embarazo , Resultado del EmbarazoRESUMEN
Echogenic bowel is diagnosed in 0.2% to 1.4% of second trimester ultrasonographic examinations. This finding occurs as a normal variant in the second trimester but also has been associated with several pathologic conditions that include cystic fibrosis, chromosomal abnormalities and in utero infection with cytomegalovirus and toxoplasmosis. Ultrasound assessment of echogenic bowel is usually subjective by comparing the echogenicity with adjacent bone or liver. The diagnosis of fetal echogenic bowel in the second trimester has significant implications for prenatal management. Fetal echogenic bowel should be considered an important marker of placental damage. This finding in the second trimester is strongly associated with adverse pregnancy outcome due to utero-placental insufficiency, particularly in women with elevated maternal serum alpha-fetoprotein concentration due to severe feto-maternal bleeding. This review focuses on the definition and diagnosis of this entity and problems raised by echogenic bowel due to subjectivity of the diagnosis. It also includes the pathophysiology in the different conditions and the prevalence of each condition. Based on this review, we suggest the evaluation that is needed, as well as the recommendations to follow-up, during the remaining term of pregnancy according to the literature.
Asunto(s)
Enfermedades Fetales/diagnóstico por imagen , Enfermedades Intestinales/diagnóstico por imagen , Enfermedades Intestinales/embriología , Intestinos/anomalías , Intestinos/diagnóstico por imagen , Ultrasonografía Prenatal , Fibrosis Quística/diagnóstico por imagen , Fibrosis Quística/embriología , Femenino , Humanos , Intestinos/embriología , Embarazo , Resultado del EmbarazoRESUMEN
Persistent and dysregulated inflammation, combined with an exaggerated host response is a major contributor to CF lung disease. As lung disease progresses, neutrophil accumulation in the airways ensues. Modulation of CF airway inflammation may result in either beneficial or deleterious side effects, resulting in more harm than good. Antibiotics, in particular, macrolides which act as a long-term anti-inflammatory agent with an excellent safety profile, and dornase alpha, are very interesting agents; steroids are not indicated in CF except in very special situations, and other promising agents such as leukotriene modifiers, high-dose N-acetylcysteine, anti-elastase and anti-cytokines require further research. Research should focus on early treatment, before lung damage has occurred.
Asunto(s)
Acetilcisteína/uso terapéutico , Antiinflamatorios no Esteroideos/uso terapéutico , Bronquitis/tratamiento farmacológico , Fibrosis Quística/complicaciones , Desoxirribonucleasa I/uso terapéutico , Glucocorticoides/uso terapéutico , Bronquitis/enzimología , Bronquitis/etiología , Fibrosis Quística/embriología , Depuradores de Radicales Libres/uso terapéutico , Humanos , Inflamación , Elastasa Pancreática/antagonistas & inhibidores , Proteínas Recombinantes/uso terapéutico , Resultado del TratamientoRESUMEN
OBJECTIVES: To determine whether there was any evidence of long-term bowel pathology in children, apparently healthy at birth, who had a prenatal second-trimester diagnosis of isolated grade 2 fetal echogenic bowel. METHODS: This was a retrospective study using data from the Oxford Congenital Anomaly Register. Fetuses with isolated grade 2 fetal echogenic bowel and date of delivery from 1994 to 2000 inclusive were identified. Information about the health of the children, particularly relating to bowel symptoms, was obtained from hospital records and from a questionnaire sent to the general practitioner. RESULTS: A total of 109 cases were identified, with delivery details available for 108. There was one unexplained intrauterine death, and additional problems were subsequently diagnosed in four cases (cystic fibrosis (2), Down syndrome (1), and VACTERL (1)). Questionnaires were sent to the GPs of the 103 who had no problems identified at the time of discharge from the maternity hospital. Age at follow-up ranged from one to four years. Responses to the questionnaires were received from 83 (81%). Of these, 74 (89%) had not reported bowel symptoms to the GP, 9 (11%) reported symptoms relating to constipation (6), chronic abdominal pain (1), infantile colic with milk intolerance (1) and gastro-oesophageal reflux (1). CONCLUSION: This small study provides some reassurance that there was no evidence of any serious long-term bowel pathology associated with isolated fetal echogenic bowel.
Asunto(s)
Enfermedades Intestinales/epidemiología , Intestinos/anomalías , Preescolar , Fibrosis Quística/diagnóstico , Fibrosis Quística/diagnóstico por imagen , Fibrosis Quística/embriología , Síndrome de Down/diagnóstico , Síndrome de Down/diagnóstico por imagen , Síndrome de Down/embriología , Inglaterra/epidemiología , Femenino , Estudios de Seguimiento , Edad Gestacional , Humanos , Lactante , Enfermedades Intestinales/etiología , Intestinos/diagnóstico por imagen , Intestinos/embriología , Masculino , Embarazo , Segundo Trimestre del Embarazo , Sistema de Registros , Estudios Retrospectivos , Encuestas y Cuestionarios , Sobrevivientes , Ultrasonografía PrenatalAsunto(s)
Regulador de Conductancia de Transmembrana de Fibrosis Quística/genética , Fibrosis Quística/epidemiología , Fibrosis Quística/genética , Pruebas Genéticas , Adulto , Teorema de Bayes , Niño , Preescolar , Fibrosis Quística/diagnóstico por imagen , Fibrosis Quística/embriología , Femenino , Genotipo , Humanos , Lactante , Masculino , Mutación , Linaje , Embarazo , Segundo Trimestre del Embarazo , Estudios Retrospectivos , Australia del Sur/epidemiología , Ultrasonografía PrenatalRESUMEN
Mammalian cloning by nuclear transfer from somatic cells has created new opportunities to generate animal models of genetic diseases in species other than mice. Although genetic mouse models play a critical role in basic and applied research for numerous diseases, often mouse models do not adequately reproduce the human disease phenotype. Cystic fibrosis (CF) is one such disease. Targeted ablation of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in mice does not adequately replicate spontaneous bacterial infections observed in the human CF lung. Hence, several laboratories are pursuing alternative animal models of CF in larger species such as the pig, sheep, rabbits, and ferrets. Our laboratory has focused on developing the ferret as a CF animal model. Over the past few years, we have investigated several experimental parameters required for gene targeting and nuclear transfer (NT) cloning in the ferret using somatic cells. In this review, we will discuss our progress and the hurdles to NT cloning and gene-targeting that accompany efforts to generate animal models of genetic diseases in species such as the ferret.
Asunto(s)
Fibrosis Quística/genética , Modelos Animales de Enfermedad , Hurones/genética , Técnicas de Transferencia Nuclear , Animales , Núcleo Celular/fisiología , Clonación de Organismos/métodos , Fibrosis Quística/embriología , Hurones/embriología , Fibroblastos/citología , Fibroblastos/metabolismoRESUMEN
Cystic fibrosis (CF) is an autosomal recessive disease characterized by obstruction and chronic infection of the respiratory tract and pancreatic insufficiency. The first preimplantation genetic diagnosis (PGD) for CF was carried out in 1992. At our centre the first cycle was performed in 1993. However, the number of known CF mutations is >1000, so developing mutation-specific PCR protocols for PGD is unfeasible. This is why a number of marker-based duplex PCRs were developed at the single cell level. A duplex PCR of a mutation and one or two microsatellites is not only a diagnostic tool, but it can also be used as a control for allele drop-out and contamination. During PGD, embryos obtained in vitro are analysed for the presence or absence of a particular genetic disease, after which only embryos shown to be free of this disease are returned to the mother. In total, 22 PGD cycles with duplex PCR (IVS8CA/IVS17BTA, DeltaF508/IVS8CA, DeltaF508/IVS17BTA and D7S486/D7S490) were carried out in 16 couples, which resulted in four ongoing pregnancies and one miscarriage.
Asunto(s)
Fibrosis Quística/diagnóstico , Fibrosis Quística/genética , Pruebas Genéticas/métodos , Mutación/genética , Reacción en Cadena de la Polimerasa/métodos , Polimorfismo Genético/genética , Diagnóstico Preimplantación/métodos , Biopsia , Blastómeros/metabolismo , Fibrosis Quística/embriología , Femenino , Marcadores Genéticos/genética , Heterocigoto , Humanos , Linfocitos/citología , Linfocitos/metabolismo , Masculino , Inyecciones de Esperma IntracitoplasmáticasRESUMEN
The cystic fibrosis transmembrane conductance regulator (CFTR) protein is a small conductance chloride ion channel that may interact directly with other channels including the epithelial sodium channel (ENaC). CFTR is known to be more abundant in the airway epithelium during the second trimester of human development than after birth. This could be a consequence of the change in function of the respiratory epithelium from chloride secretion to sodium absorption near term. Alternatively it might reflect an additional role for CFTR in the developing airway epithelium. Though the lung epithelia of CF fetuses and infants rarely show gross histological abnormalities, there is often evidence of inflammation. Our aim was to establish whether CFTR expression levels correlated with specific developmental stages or differentiated functions in the ovine fetal lung. We evaluated CFTR expression using a quantitative assay of mRNA at 14 time points through gestation and showed highest levels at the start of the second trimester followed by a gradual decline through to term. In contrast, ENaC expression increased from the start of the third trimester. These results support a role for CFTR in differentiation of the respiratory epithelium and suggest that its expression levels are not merely reflecting major changes in the sodium/chloride bulk flow close to term. These observations may have significant implications for the likely success of CF gene therapy in the postnatal lung.
Asunto(s)
Regulador de Conductancia de Transmembrana de Fibrosis Quística/genética , Regulación de la Expresión Génica , Pulmón/embriología , Animales , Fibrosis Quística/embriología , Fibrosis Quística/terapia , Regulador de Conductancia de Transmembrana de Fibrosis Quística/biosíntesis , Regulación hacia Abajo , Femenino , Pulmón/metabolismo , Masculino , Datos de Secuencia Molecular , ARN Mensajero , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Ovinos , Distribución TisularRESUMEN
PURPOSE: Duodenal atresia is associated with a higher incidence of associated congenital malformations than jejunoileal atresia, supporting the hypothesis that the duodenal obstruction occurs early in fetal life. In this study, the authors analyzed the incidence of major associated malformations in jejunal atresia (JA) and ileal atresia (IA) to determine if there is a positive correlation between the proximity of the intestinal atresia and the association of other major anomalies. METHODS: Records of all patients with jejunoileal atresias treated at the authors' institution between 1980 and 1997 were examined. RESULTS: There were 83 patients with jejunoileal atresias, 38 with JA, and 45 with IA. Sixteen (42%) of the JA patients had an associated major congenital malformation, whereas only 1 (2%) of the IA patients had an associated malformation. A single atresia was found in 18 (47%) of JA patients and 41 (91%) of IA patients. Twenty (53%) of the JA patients had either multiple or apple-peel atresia. Thirteen patients (16%) died, 11 with JA, and 2 with IA. Of the 11 patients with JA who died, 6 had multiple atresias, 4 had cystic fibrosis, and 1 had small bowel volvulus. CONCLUSION: The higher incidence of associated major congenital extraintestinal malformations in JA compared with IA patients suggests that some cases of JA may arise from a malformative process.